Blood loss is one of the leading causes of death in physical injuries. In critical cases of physical trauma, managing blood loss and achieving quicker clotting than the body’s natural clotting process becomes crucial. For that, physicians and healthcare professionals commonly use hemostatic agents like hemostatic gels.
Antibacterial haemostatic gels are a specialized version of hemostatic gels primarily used for wound management and controlling bleeding. In this blog post, we offer an overview of these haemostatic gels and explore the growth drivers, recent developments, and top segments in the antibacterial haemostatic gels market.
What Exactly is Haemostatis?
Haemostasis is the process of stopping blood flow from a blood vessel. Haemostasis can be:
Natural: Here, the body itself limits blood loss and ultimately stops it.
Induced: Induced haemostasis is when an external object is used to stop blood flow.
Haemostasis is usually induced during surgical procedures where healthcare professionals must stop blood flow. Also, it can be done to stop blood flow from deep cuts and life-threatening injuries.
Growth Drivers
According to a new study by Polaris Market Research and Consulting, the antibacterial haemostatic gels market was valued at USD 1,312.90 million in 2022 and is expected to grow to USD 2,452.94 million at a CAGR of 6.5% in 2032.
The growing prevalence of chronic wounds like leg ulcers and diabetic foot is becoming a healthcare concern in several regions worldwide. Also, the incidences of chronic wounds are projected to increase as the global population ages. Antibacterial haemostatic gels are widely used to manage these wounds, favorably impacting market sales.
Additionally, there has been a significant rise in surgical procedures worldwide. Antibacterial haemostatic gels are extensively used in several surgical operations to manage bleeding and prevent the spread of infections. This increase in surgical procedures is another factor spurring the demand for antibacterial hemostatic gels.
Type of Haemostats
Haemostats developed by antibacterial haemostatic gels market key players and other manufacturers can broadly be classified into the following two types:
Active haemostats: As their name implies, the components of active haemostats actively participate in the blood clotting process. This haemostat type increases the speed of biological changes that occur in the body during healing.
Mechanical haemostats: These haemostats provide a sterile surface that allows for rapid blood clot formation through natural clotting. This haemostat type is known for its ease of use as it only requires healthcare professionals to apply manual pressure on the bleeding site.
The Urine analysis Testing Kits Segment Dominates the Market
The urine analysis testing kits segment accounted for the largest revenue share in 2022. These kits are used to analyze urine for several purposes, including diagnosing diseases and monitoring health conditions. These kits usually include strips with chemical reagents that react with urine to offer important data on various parameters.
Regional Analysis
North America: The antibacterial haemostatic gels market in North America region is projected to grow at the fastest rate over the forecast period. This is primarily because the region is a leader in technological advancements and innovations, giving them a competitive edge in the market. Besides, the presence of advanced healthcare infrastructure is another factor bolstering the industry’s growth in the region.
Europe: The European region accounted for a significant market share in 2022. This can be attributed to the growing number of surgeries in several European countries. For instance, the year 2020 saw over 3,102,674 surgical procedures being performed in England and Wales. The UK National Health Service also performs over 1.5 million surgical treatments every year. As a result, the demand for antibacterial hemostatic gels is expected to rise in the region.
Recent Developments
In July 2021, Medcura partnered with U.S. first aid supplier ASO LLC to create a new high-performance antibacterial haemostatic gel Rapid-Seal. The product is available at various large pharmacy chains in the US.
Final Saying
Antibacterial haemostatic gels are renowned for their enhanced antimicrobial efficacy and ease of application. Technological advancements have led to the development of more enhanced antibacterial hemostatic gels and are impacting the antibacterial haemostatic gels market favorably.